Table 1. The expression of CENPK versus clinical features.
Clinicopathological parameters |
Number of patients | Upregulation* | no up-regulation | X2 | P |
---|---|---|---|---|---|
Age (years) | |||||
≥ 65years | 16 | 11 | 5 | 0.51 | > 0.05 |
< 65 years | 81 | 48 | 33 | ||
Gender | |||||
Male | 81 | 49 | 32 | 0.01 | > 0.05 |
Female | 17 | 11 | 6 | ||
HBV | |||||
HBV (+) | 61 | 54 | 29 | 2.50 | > 0.05 |
HBV (−) | 6 | 6 | 8 | ||
Tumor size | |||||
≥ 3 cm | 81 | 48 | 33 | 0.01 | < 0.05 |
< 3 cm | 9 | 6 | 3 | ||
Lymphatic metastasis | |||||
Present | 3 | 1 | 2 | 0.19 | > 0.05 |
Absent | 102 | 64 | 38 | ||
AFP | |||||
≥ 400 ng/ml | 36 | 26 | 10 | 4.38 | < 0.05 |
< 400 ng/ml | 41 | 20 | 21 |
*:up regulation of CENP-K was designed as ≥ 2(HCC/non-HCC).